Liptruzet - atorvastatin and ezetimibe

Liptruzet contains a combination of atorvastatin and ezetimibe.

Ezetimibe reduces the amount of cholesterol absorbed by the body.

Atorvastatin belongs to a group of drugs called HMG CoA reductase inhibitors, or “statins.”

Liptruzet reduces blood levels of “bad” cholesterol, such as low-density lipoprotein (LDL), apolipoprotein-B (apo-B), triglycerides, or non-high-density lipoprotein (non-HDL).

Liptruzet is used together with a low-fat diet and other treatments to lower total cholesterol in adults with familial hypercholesterolemia (an inherited type of high cholesterol).

It is not known whether Liptruzet reduces your risk of heart disease.

Side effects include:

  • ALT increased (5%), AST increased (4%)
  • Musculoskeletal pain (3.8 to 4%)
  • arthralgia (3 to 6.9%)
  • pain in extremity (2.7 to 6%)
  • myalgia (3.5%)
  • muscle spasms (3%)
  • muscle weakness (2%)
  • Diarrhea (4.1 to 6.8%)
  • abdominal pain (3%)
  • nausea (3 to 4%)
  • dyspepsia (4.7%)
  • Dizziness (2 to 6%)
  • insomnia (3%)
  • fatigue (2.4%)
  • Hyperkalemia (2%)
  • Hot flushes (2%)
  • Urinary tract infection (5.7%)

 

 

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.